The Clinical Course of Takotsubo Syndrome Diagnosed According to the InterTAK Criteria

Imagem de Miniatura
Arquivos
art_FUNDÃO_The_Clinical_Course_of_Takotsubo_Syndrome_Diagnosed_According_2020.PDF (729.99 KB)
Citações na Scopus
1
Tipo de produção
article
Data de publicação
2020
DOI
SciELO
Scopus
Título da Revista
ISSN da Revista
Título do Volume
Editora
Sociedade Brasileira de Cardiologia
Autores
Citação
INTERNATIONAL JOURNAL OF CARDIOVASCULAR SCIENCES, v.33, n.6, p.637-647, 2020
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Abstract Background There has been an increase in the number of cases of Takotsubo syndrome (TTS) and of scientific publications on the theme over the last years. However, little is known about the status of this disease in Brazilian hospitals. Objective To assess mortality and major adverse cardiovascular events (MACE) during hospitalization and follow-up of TTS patients seen in a tertiary hospital in Brazil. Methods This was a retrospective, observational study on 48 patients. Clinical data, signs and symptoms, complementary tests, MACE and all-cause mortality were assessed on admission and during follow-up. Kaplan-Meier curves were used for analysis of all-cause mortality and risk for MACE at median follow-up. The 95% confidence interval was also calculated for a significance level of 5%. Results Mean age of patients was 71 years (SD±13 years), and most patients were women (n=41; 85.4%). During hospitalization, four patients (8.3%) died and five (10.4%) developed MACE. At median follow-up of 354.5 days (IQR of 81.5-896.5 days), the risk of all-cause mortality and MACE was 11.1% (95% CI= 1.8-20.3%) and 12.7% (95% CI= 3.3-22.3%), respectively. Conclusion TTS was associated with high morbidity and mortality rates in a tertiary hospital in Brazil, which were comparable to those observed in acute coronary syndrome. Therefore, the severity of TTS should not be underestimated, and new therapeutic strategies are required. Int J Cardiovasc Sci. 2020; [online].ahead print, PP.0-0
Palavras-chave
Acute Coronary Syndrome, Takotsubo Cardiomyopathy, Heart Failure, Shock, Cardiogenic, Ventricular Dysfunction
URI
https://observatorio.fm.usp.br/handle/OPI/39622
Referências
  1. Abe Y, 2003, HEART, V89, P974, DOI 10.1136/heart.89.9.974
  2. Blazquez JA, 2010, INTERACT CARDIOV TH, V11, P117, DOI 10.1510/icvts.2010.234013
  3. Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872
  4. Bybee KA, 2004, ANN INTERN MED, V141, P858, DOI 10.7326/0003-4819-141-11-200412070-00010
  5. Rivera AMC, 2011, MED SCI MONITOR, V17, pRA135, DOI 10.12659/MSM.881800
  6. Cerqueira MD, 2002, CIRCULATION, V105, P539, DOI 10.1161/hc0402.102975
  7. Chiariello GA, 2016, J CARDIAC SURG, V31, P89, DOI 10.1111/jocs.12675
  8. Cubero JS, 2004, REV ESP CARDIOL, V57, P194
  9. El-Sayed AM, 2012, AM J CARDIOL, V110, P1368, DOI 10.1016/j.amjcard.2012.06.041
  10. Elesber AA, 2007, J AM COLL CARDIOL, V50, P448, DOI 10.1016/j.jacc.2007.03.050
  11. Gaibazzi N, 2009, INT J CARDIOL, V133, P205, DOI 10.1016/j.ijcard.2007.12.037
  12. Ghadri JR, 2018, EUR HEART J, V39, P2047, DOI 10.1093/eurheartj/ehy077
  13. Ghadri JR, 2018, EUR HEART J, V39, P2032, DOI 10.1093/eurheartj/ehy076
  14. Ionescu A, 2008, EUR J ECHOCARDIOGR, V9, P384, DOI 10.1016/j.euje.2006.11.011
  15. Itoh Hideshi, 2007, J Extra Corpor Technol, V39, P109
  16. Kato K, 2017, HEART, V103, P1461, DOI 10.1136/heartjnl-2016-309783
  17. Kawai S, 2007, CIRC J, V71, P990, DOI 10.1253/circj.71.990
  18. Kawaji T, 2015, CIRC J, V79, P839, DOI 10.1253/circj.CJ-14-1148
  19. Kurisu S, 2002, AM HEART J, V143, P448, DOI 10.1067/mhj.2002.120403
  20. Kurisu S, 2009, CORONARY ARTERY DIS, V20, P214, DOI 10.1097/MCA.0b013e3283299260
  21. Lyon AR, 2016, EUR J HEART FAIL, V18, P8, DOI 10.1002/ejhf.424
  22. Napp LC, 2015, INT J CARDIOL, V197, P257, DOI 10.1016/j.ijcard.2015.06.043
  23. Otten AM, 2016, NETH HEART J, V24, P520, DOI 10.1007/s12471-016-0859-x
  24. Prasad A, 2008, AM HEART J, V155, P408, DOI 10.1016/j.ahj.2007.11.008
  25. Redfors B, 2015, INT J CARDIOL, V185, P282, DOI 10.1016/j.ijcard.2015.03.162
  26. Redfors B, 2014, J GERIATR CARDIOL, V11, P171, DOI 10.3969/j.issn.1671-5411.2014.02.001
  27. Santoro F, 2016, CARDIOVASC THER, V34, P161, DOI 10.1111/1755-5922.12182
  28. Shams Y., 2015, INT J CARDIOL RES, V2, P28, DOI [10.19070/2470-4563-150007, DOI 10.19070/2470-4563-150007]
  29. Sharkey SW, 2011, CIRCULATION, V124, pE460, DOI 10.1161/CIRCULATIONAHA.111.052662
  30. Stiermaier T, 2016, EUR HEART J-ACUTE CA, V5, P489, DOI 10.1177/2048872615612456
  31. Templin C, 2015, NEW ENGL J MED, V373, P929, DOI 10.1056/NEJMoa1406761
  32. Thygesen K, 2019, EUR HEART J, V40, P237, DOI [10.1016/j.jacc.2018.08.1038, 10.1093/eurheartj/ehy462]
  33. Tornvall P, 2016, J AM COLL CARDIOL, V67, P1931, DOI 10.1016/j.jacc.2016.02.029
  34. Tsuchihashi K, 2001, J AM COLL CARDIOL, V38, P11, DOI 10.1016/S0735-1097(01)01316-X
  35. Winchester DE, 2008, CATHETER CARDIO INTE, V72, P612, DOI 10.1002/ccd.21738
  36. Zeng JH, 2019, BMC Cardiovasc Disord, V19

Coleções
Artigos e Materiais de Revistas Científicas - FM/MCP
Artigos e Materiais de Revistas Científicas - HC/ICESP
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - HC/InCor
Artigos e Materiais de Revistas Científicas - LIM/08